Other Events ·
Nasdaq notifies Health In Tech of non-compliance with $1.00 minimum bid price and director independence rules
HITHealth In Tech, Inc.
Health In Tech, Inc. received two notices from Nasdaq regarding listing compliance failures. First, the company is not in compliance with independent director and audit committee requirements following the resignation of Sanjay Shrestha on August 10, 2026. The Board has four directors, only two of whom are independent, and the Audit Committee has only two members. Compliance must be achieved by the next annual meeting or August 10, 2027. Second, Nasdaq notified the company that its Class A common stock closed below $1.00 per share for 30 consecutive business days. The company has until April 12, 2027, to regain compliance by maintaining a bid price of at least $1.00 for ten consecutive business days or by effecting a reverse stock split. Health In Tech operates in the health technology sector.